Two recent studies present a new approach for bone marrow donation and transplant that preclinical laboratory tests suggest could make the life-saving procedure safer and more effective for patients. Researchers report the studies demonstrate that use of an experimental drug called CASIN in laboratory mice results in higher efficiency when harvesting blood stem cells from donors and less toxicity in transplant recipients.
About The Author
21 December, 2016
Our Facebook Page
Facebook By Weblizar Powered By Weblizar
amniotic stem cells Biology Biotech california stem cells California Stem Cell Treatment Center Cancer Cell Surgical Network CIRM CRISPR Daily Daily News fat stem cells fda FDA stem cells Health iPS cells Jeanne Loring Kristin Comella Leigh Turner Medical research Pharma Research review Science Society Startups stem cell clinic stem cell clinical trials stem cell clinics stem cell law stem cell lawsuit Stem Cell News Stem Cell Research Stem cells Stem Cell Therapy stem cell treatment stem cell treatment cost Stemgenex SYN The Nutshell Top Story Uncategorized USRM Viacyte World news